TMEM215
Transmembrane protein 215
Also known as: TM215_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q68D42
- Gene
- TMEM215
- Ensembl
- ENSG00000188133
- Chromosome
- 9
- Canonical length
- 235 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
Predicted to act upstream of or within negative regulation of retinal cell programmed cell death and sprouting angiogenesis. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
235 residues, UniProt reviewed canonical sequence.
>Q68D42|TMEM215
1 MRPDDINPRT GLVVALVSVF LVFGFMFTVS GMKGETLGNI PLLAIGPAIC LPGIAAIALA
61 RKTEGCTKWP ENELLWVRKL PCFRKPKDKE VVELLRTPSD LESGKGSSDE LAKKAGLRGK
121 PPPQSQGEVS VASSINSPTP TEEGECQSLV QNGHQEETSR YLDGYCPSGS SLTYSALDVK
181 CSARDRSECP EPEDSIFFVP QDSIIVCSYK QNSPYDRYCC YINQIQGRWD HETIVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM215 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- retina: 17 nTPM
- testis: 2.5 nTPM
- endometrium: 2.1 nTPM
- ovary: 2.1 nTPM
- thyroid gland: 0.8 nTPM
- cervix: 0.6 nTPM
Single-cell type
- late spermatids: 575 nCPM
- retinal bipolar cells: 477 nCPM
- early spermatids: 158 nCPM
- retinal amacrine cells: 26 nCPM
- late primary spermatocytes: 12 nCPM
- brain inhibitory neurons: 6.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 14 nTPM
- midbrain: 3.7 nTPM
- amygdala: 2.8 nTPM
- basal ganglia: 2.1 nTPM
- thalamus: 1.7 nTPM
- hippocampal formation: 1.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.58
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.82
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of endothelial cell apoptotic process
- negative regulation of programmed necrotic cell death
- negative regulation of retinal cell programmed cell death
- sprouting angiogenesis
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transmembrane protein 215
- TMEM215 family
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM215 as an antibody target. Whether an autoantibody or antibody against TMEM215 could matter depends on whether native TMEM215 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM215 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM215 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...